Ryan O'Hanlon
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$2.3MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $2.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 29, 2025 | NIH | SBIR Phase I In vivo imaging platform for DM1 drug discovery | $313K | LUCERNA INC |
| Jul 29, 2024 | NIH | SBIR Phase I Targeted RNA degradation assay for new antiviral drug discovery | $300K | LUCERNA INC |
| Nov 17, 2023 | NIH | SBIR Phase I Cell-based RNA degradation assay for C9ALS/FTD drug discovery | $392K | LUCERNA INC |
| Mar 30, 2020 | NIH | SBIR Phase I Cell-based assay directly monitoring RNA Polymerase I activity for cancer drug discovery | $224K | LUCERNA INC |
| Mar 20, 2020 | NIH | SBIR Phase II Splice sensors for cancer drug discovery | $533K | LUCERNA INC |
| Dec 5, 2019 | NIH | SBIR Phase I Cell-based assay directly monitoring viral polymerase activity for drug discovery. | $224K | LUCERNA INC |
| Jun 17, 2019 | NIH | SBIR Phase II Splice sensors for cancer drug discovery | $355K | LUCERNA INC |
Peer ranks
Federal funding#836
Awards as PI#250
Patents#273
Companies
- LUCERNA INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.